To induce a mouse model of scleroderma with repeated bleomycin injections for research into human scleroderma at our research laboratory.
대상 및 방법
동물 선정 및 bleomycin처리는 기존의 방법을 그 대로 적용하였다 (5). 약술하면 다음과 같다. Histopathologic comparison of dermal thickness and fibrosis in C3H/He mice. Mice were treated with PBS 100 μg/ml (1), bleomycin 10 μg/ml (2), or bleomycin 100 μg/ml (3) for 28 days (A: H&E stain, B: Masson's Trichrome stain, magnification ×100). There was no dermal sclerosis or fibrosis in the PBS-treated group. However, bleomycin-treated mice showed increase of dermal thickness and fibrosis. The dermis from the bleomycin-treated group was filled with thickened and homogeneous collagen bundles with cellular infiltrates.
Fig. 2.
Dermal thickness in PBS-or bleomycin-treated mice. H-E stained skin section of mice were evaluated by two pathologists blinded to the treatment group. Repeated injection of bleomycin (10 μg/ml) did not affect dermal thickness; however, 100 μg/ ml of bleomycin significantly increased the dermal thickness (by ANOVA). NS: non-significant, PBS: phosphate buffered saline, BLM: bleomycin. 참고문헌
